Skip to main navigation
Login · Contact

Akorn Pharmaceuticals

  • ABOUT US
    • Corporate Profile
    • Timeline
    • Operating Locations
    • Compliance
    • Code of Ethics
    • Quality Policy
  • OUR BUSINESSES
    • Generics
    • Brand Rx
    • Akorn Consumer Health
    • Akorn Animal Health
    • Akorn India
  • PRODUCTS
    • All Products
    • Download Catalogs
    • Return Goods Policy
  • BUSINESS DEVELOPMENT
    • Benefits of Partnering
  • INVESTOR RELATIONS
    • Stock Quote & Chart
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • IR Contacts
  • CAREERS
    • Who We Are
    • Why We Work Here
    • Career Opportunities
    • Benefits
Akorn Investor Relations

INVESTOR RELATIONS

Investor Relations Stock Quote & Chart Press Releases Events & Presentations SEC Filings Annual Reports Analyst Coverage Corporate Governance
Charters and Documents Management Board of Directors
Investor FAQs IR Contacts Contact Us

Tool Kit

E-mail Alerts Print Page RSS Feeds

Share Page

X
  • Share on:
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Reddit
  • Digg
  • Google
  • Delicious
  • StumbleUpon

  • Share this page through your favorite social channel or email this page to a colleague.

SEC Filing Details

Document Details

Form
4/A
Filing Date
09/09/14
Document Date
05/02/14
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Akorn, Inc.
Issuer
AKORN INC
Filer
TAMBI BRIAN

Filing Formats

View HTML
Download PDF
Download DOC

Advancing The New Vision

  • Home
  • Contact Us
  • Legal & Privacy
  • Site Map

©Akorn, Incorporated | 1925 W. Field Court, Lake Forest, Illinois 60045 | 800.932.5676